Single Centre, Prospective, Open, Non Controlled, Pilot Study for Efficacy and Security Evaluation of Low Nephrotoxicity Immunosuppression, Based on the Use of ATeGe in Liver Transplant Recipients With Pre-transplant Renal Dysfunction.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antithymocyte globulin (Primary)
- Indications Liver transplant rejection
- Focus Therapeutic Use
- 12 Feb 2020 Biomarkers information updated
- 17 Jan 2012 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 19 Oct 2011 New trial record